Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience

Clin Oncol (R Coll Radiol). 2001;13(1):66.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / surgery
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma / drug therapy*
  • Carcinoma / surgery
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / surgery
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Epirubicin / administration & dosage
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / surgery
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / surgery
  • Survival Analysis
  • Treatment Outcome

Substances

  • Epirubicin
  • Cisplatin
  • Fluorouracil

Supplementary concepts

  • FPEPIR regimen